6-Benzylthioinosine

6-Benzylthioinosine is a compound with antileukemic activity that increases cytotoxicity against acute myeloid leukemia cells when combined with Metformin (HY-B0627), modulating cellular metabolism and signaling pathways through multiple mechanisms. 6-Benzylthioinosine is also a potential precursor inhibitor of mammalian nucleoside transporter ENT1 (es), and its derivatives have anti-Toxoplasma activity.